Strong Tower Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Strong Tower Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-44,371	Closed	-$3.42M	–	97
2022 Q2	$3.42M	Buy	44,371 +110	+0.2%	+$8.38K	1.85%	11
2022 Q1	$3.23M	Buy	44,261 +716	+2%	+$48.1K	1.65%	15
2021 Q4	$2.71M	Buy	43,545 +5,254	+14%	+$308K	1.45%	26
2021 Q3	$2.19M	Buy	+38,291	New	+$2.52M	1.27%	24

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strong Tower Advisory Services's BMY Position: Q3 2022 in Review

Strong Tower Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 44,371 shares — an estimated $3.42M sold.

Strong Tower Advisory Services first reported a position in BMY in Q3 2021 and held it in 4 quarters. The position peaked at $3.42M in Q2 2022. 2,472 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Strong Tower Advisory Services reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Strong Tower Advisory Services sold 44,371 Bristol-Myers Squibb shares in Q3 2022, an estimated $3.42M.
Strong Tower Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 4 quarters.
Strong Tower Advisory Services's Bristol-Myers Squibb position peaked at $3.42M in Q2 2022.
2,472 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Strong Tower Advisory Services's 13F filing for Q3 2022, filed 14 Oct 2022.